BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 27652271)

  • 1. Involvement of Histone Lysine Methylation in p21 Gene Expression in Rat Kidney In Vivo and Rat Mesangial Cells In Vitro under Diabetic Conditions.
    Li X; Li C; Li X; Cui P; Li Q; Guo Q; Han H; Liu S; Sun G
    J Diabetes Res; 2016; 2016():3853242. PubMed ID: 27652271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone Lysine Methylation in TGF-β1 Mediated p21 Gene Expression in Rat Mesangial Cells.
    Guo Q; Li X; Han H; Li C; Liu S; Gao W; Sun G
    Biomed Res Int; 2016; 2016():6927234. PubMed ID: 27247942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells.
    Yuan H; Reddy MA; Sun G; Lanting L; Wang M; Kato M; Natarajan R
    Am J Physiol Renal Physiol; 2013 Mar; 304(5):F601-13. PubMed ID: 23235480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-β1-induced gene expression in mesangial cells and diabetic kidney.
    Jia Y; Reddy MA; Das S; Oh HJ; Abdollahi M; Yuan H; Zhang E; Lanting L; Wang M; Natarajan R
    J Biol Chem; 2019 Aug; 294(34):12695-12707. PubMed ID: 31266808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.
    Yuan H; Reddy MA; Deshpande S; Jia Y; Park JT; Lanting LL; Jin W; Kato M; Xu ZG; Das S; Natarajan R
    Antioxid Redox Signal; 2016 Mar; 24(7):361-75. PubMed ID: 26492974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic histone methylation modulates fibrotic gene expression.
    Sun G; Reddy MA; Yuan H; Lanting L; Kato M; Natarajan R
    J Am Soc Nephrol; 2010 Dec; 21(12):2069-80. PubMed ID: 20930066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis.
    Goru SK; Kadakol A; Pandey A; Malek V; Sharma N; Gaikwad AB
    Biochem J; 2016 Nov; 473(21):3937-3949. PubMed ID: 27582499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription Factor Egr1 is Involved in High Glucose-Induced Proliferation and Fibrosis in Rat Glomerular Mesangial Cells.
    Wang D; Guan MP; Zheng ZJ; Li WQ; Lyv FP; Pang RY; Xue YM
    Cell Physiol Biochem; 2015; 36(6):2093-107. PubMed ID: 26279418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells.
    Kato M; Arce L; Wang M; Putta S; Lanting L; Natarajan R
    Kidney Int; 2011 Aug; 80(4):358-68. PubMed ID: 21389977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions.
    Park JT; Kato M; Lanting L; Castro N; Nam BY; Wang M; Kang SW; Natarajan R
    Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1390-403. PubMed ID: 25354942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
    Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
    Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone methyltransferase Suv39h1 attenuates high glucose-induced fibronectin and p21(WAF1) in mesangial cells.
    Lin SH; Ho WT; Wang YT; Chuang CT; Chuang LY; Guh JY
    Int J Biochem Cell Biol; 2016 Sep; 78():96-105. PubMed ID: 27373678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway.
    Yang J; Kan M; Wu GY
    Immunopharmacol Immunotoxicol; 2016; 38(2):145-52. PubMed ID: 26954391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deacetylation of S6 kinase promotes high glucose-induced glomerular mesangial cell hypertrophy and matrix protein accumulation.
    Das F; Maity S; Ghosh-Choudhury N; Kasinath BS; Ghosh Choudhury G
    J Biol Chem; 2019 Jun; 294(24):9440-9460. PubMed ID: 31028173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
    Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
    Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP.
    Li Y; Ren D; Shen Y; Zheng X; Xu G
    EBioMedicine; 2020 Jan; 51():102582. PubMed ID: 31901873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes.
    Komers R; Mar D; Denisenko O; Xu B; Oyama TT; Bomsztyk K
    Lab Invest; 2013 May; 93(5):543-52. PubMed ID: 23508046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway.
    Zheng JM; Zhu JM; Li LS; Liu ZH
    Br J Pharmacol; 2008 Apr; 153(7):1456-64. PubMed ID: 18264122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.